Empowered Funds
NAUT icon

Empowered Funds’s Nautilus Biotechnolgy NAUT Stock Holding History

Empowered Funds’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$106K Buy
+75,000
New +$89.1K ﹤0.01% 2407

Other funds holding NAUT

Cercano Management
Cercano Management Bellevue, Washington $729M AUM 20.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
Sentinel Trust
Sentinel Trust Houston, Texas $1.19B AUM 19.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Empowered Funds's NAUT Position: Q3 2026 in Review

Empowered Funds opened a new position in Nautilus Biotechnolgy (NAUT) in Q3 2026: 75,000 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #2407 among its holdings.

59 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

  • Empowered Funds held 75,000 shares of Nautilus Biotechnolgy worth $106K as of Q3 2026.
  • Nautilus Biotechnolgy was a new Empowered Funds position in Q3 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2407 holding.
  • 59 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.